Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage

about

Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage

Item

http://www.wikidata.org/entity/Q36912173

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Safety and efficiency of recom ...... tcardiotomy massive hemorrhage

@en

type

Item

label

Safety and efficiency of recom ...... tcardiotomy massive hemorrhage

@en

prefLabel

Safety and efficiency of recom ...... tcardiotomy massive hemorrhage

@en

P1476

Safety and efficiency of recom ...... tcardiotomy massive hemorrhage

@en

P2093

Danielle Robitaille

http://www.w3.org/2001/XMLSchema#string

Nancy C Poirier

http://www.w3.org/2001/XMLSchema#string

Philippe Demers

http://www.w3.org/2001/XMLSchema#string

Raymond Cartier

http://www.w3.org/2001/XMLSchema#string

Yoan Lamarche

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant activated factor VII for acute intracerebral hemorrhage.

Potential role for rFVIIa in transfusion medicine.

Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.

Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation.

Off-label reports of new biologics: exciting new therapy or dubious research? Examples from recombinant activated factor VII.

Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study.

Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery.

Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.

P304

809-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0828-282X(07)70832-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6137050

http://www.w3.org/2001/XMLSchema#string

P698

17703260

http://www.w3.org/2001/XMLSchema#string

P932

2651387

http://www.w3.org/2001/XMLSchema#string